Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes
Christian P. Kratz, Lude Franke, Harm Peters, et al.
British Journal of Cancer (2015) Vol. 112, Iss. 8, pp. 1392-1397
Open Access | Times Cited: 197

Showing 1-25 of 197 citing articles:

Childhood cancer predisposition syndromes—A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology
Tim Ripperger, Stefan Bielack, Arndt Borkhardt, et al.
American Journal of Medical Genetics Part A (2017) Vol. 173, Iss. 4, pp. 1017-1037
Closed Access | Times Cited: 244
Advancing therapy for neuroblastoma
Bo Qiu, Katherine K. Matthay
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 8, pp. 515-533
Closed Access | Times Cited: 222
SHP2 sails from physiology to pathology
Mylène Tajan, Audrey de Rocca Serra, Philippe Valet, et al.
European Journal of Medical Genetics (2015) Vol. 58, Iss. 10, pp. 509-525
Closed Access | Times Cited: 214
Retinoblastoma and Neuroblastoma Predisposition and Surveillance
Junne Kamihara, Franck Bourdeaut, William D. Foulkes, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 13, pp. e98-e106
Open Access | Times Cited: 198
The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway
Mylène Tajan, Romain Paccoud, Sophie Branka, et al.
Endocrine Reviews (2018) Vol. 39, Iss. 5, pp. 676-700
Open Access | Times Cited: 196
Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association
George K. Lui, Arwa Saidi, Ami B. Bhatt, et al.
Circulation (2017) Vol. 136, Iss. 20
Open Access | Times Cited: 189
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
Margaret Cristina da Silva Boguszewski, César Luiz Boguszewski, Wassim Chemaitilly, et al.
European Journal of Endocrinology (2022) Vol. 186, Iss. 6, pp. P35-P52
Open Access | Times Cited: 71
Acute lymphoblastic leukaemia
Luca Pagliaro, Sai‐Juan Chen, Daniel Herranz, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 44
Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool
Marjolijn C.J. Jongmans, Jan Loeffen, Esmé Waanders, et al.
European Journal of Medical Genetics (2016) Vol. 59, Iss. 3, pp. 116-125
Open Access | Times Cited: 158
Cognitive Dysfunctions in Intellectual Disabilities: The Contributions of the Ras-MAPK and PI3K-AKT-mTOR Pathways
Sarah C. Borrie, Hilde Brems, Eric Legius, et al.
Annual Review of Genomics and Human Genetics (2017) Vol. 18, Iss. 1, pp. 115-142
Open Access | Times Cited: 149
Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk
Anita Villani, Mary‐Louise C. Greer, Jennifer M. Kalish, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 12, pp. e83-e90
Open Access | Times Cited: 144
The Conundrum of Genetic “Drivers” in Benign Conditions
Shumei Kato, Scott M. Lippman, Keith T. Flaherty, et al.
JNCI Journal of the National Cancer Institute (2016) Vol. 108, Iss. 8, pp. djw036-djw036
Open Access | Times Cited: 136
Growth Hormone’s Links to Cancer
César Luiz Boguszewski, Margaret Cristina da Silva Boguszewski
Endocrine Reviews (2018) Vol. 40, Iss. 2, pp. 558-574
Open Access | Times Cited: 126
Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems
Venkatesh P. Kashi, Mark E. Hatley, Rene L. Galindo
Nature reviews. Cancer (2015) Vol. 15, Iss. 7, pp. 426-439
Open Access | Times Cited: 118
Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation
Karim Kouz, Christina Lißewski, Stephanie Spranger, et al.
Genetics in Medicine (2016) Vol. 18, Iss. 12, pp. 1226-1234
Open Access | Times Cited: 94
Predisposition to cancer in children and adolescents
Christian P. Kratz, Marjolijn C.J. Jongmans, Hélène Cavé, et al.
The Lancet Child & Adolescent Health (2021) Vol. 5, Iss. 2, pp. 142-154
Closed Access | Times Cited: 92
Germline Genetic Predisposition to Hematologic Malignancy
Elissa Furutani, Akiko Shimamura
Journal of Clinical Oncology (2017) Vol. 35, Iss. 9, pp. 1018-1028
Open Access | Times Cited: 90
Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum
Marialetizia Motta, Luca Pannone, Francesca Pantaleoni, et al.
The American Journal of Human Genetics (2020) Vol. 107, Iss. 3, pp. 499-513
Open Access | Times Cited: 76
Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes
Emanuele Monda, Marta Rubino, Michele Lioncino, et al.
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 68
Pediatric Rhabdomyosarcoma: Epidemiology and Genetic Susceptibility
Bailey A. Martin‐Giacalone, P. Adam Weinstein, Sharon E. Plon, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 2028-2028
Open Access | Times Cited: 61
Clinical overview on RASopathies
Martin Zenker
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 414-424
Open Access | Times Cited: 51
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe
Simone Hettmer, Corinne M. Linardic, Anna Kelsey, et al.
European Journal of Cancer (2022) Vol. 172, pp. 367-386
Open Access | Times Cited: 43
The “Bad Father”: Paternal Role in Biology of Pregnancy and in Birth Outcome
Stefano Raffaele Giannubilo, Daniela Marzioni, Giovanni Tossetta, et al.
Biology (2024) Vol. 13, Iss. 3, pp. 165-165
Open Access | Times Cited: 12
Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation
Andrew Dodgshun, Nadine SantaCruz, Jaeho Hwang, et al.
Journal of Neuro-Oncology (2016) Vol. 128, Iss. 2, pp. 293-302
Closed Access | Times Cited: 61
NRASStatus Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS–MAPK Pathway in Neuroblastoma
Ivette Valencia-Sama, Yagnesh Ladumor, Lynn Kee, et al.
Cancer Research (2020) Vol. 80, Iss. 16, pp. 3413-3423
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top